We partner with research scientists and clinicians who want to take their new drug discoveries to market but lack the resources to do it on their own. We raise the capital, form the team, and develop the strategy needed to advance each compound through the early stages of FDA drug development. We manage the entire development program from preclinical to Phase II proof of concept, where we secure licensing exits with pharma groups who take the drugs the rest of the way through Phase III pivotal trials, regulatory approval, to commercial success.